2875 completed, 914 unknown, 802 recruiting, 546 terminated. 1651 Phase 2, 1299 Phase 1, 1197 Not applicable, 546 Phase 3, 291 Phase 4.
Follow Gonadal Disorders: new trials by email Literature Review of Gonadal Disorders trials Research Report on Gonadal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors Exercise and dietary recommendations - Ovarian Cancer | Not applicable | Not yet recruiting | Oncare Madrid | 32 | 2028-05-01 | 2026-10-08 |
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| A Dose Ranging Study to Examine TDS-Testosterone 5% Testosterone, Pump Sprayer - Hypogonadotropism | Phase 2 | Not yet recruiting | Transdermal Delivery Solutions Corp | 48 | 2027-06-01 | 2026-09-30 |
| PITCH - Impacting Hereditary Cancer Testing Genetic testing education video - Ovarian Cancer, Genetic Testing | Not applicable | Not yet recruiting | Rachel Miller | 200 | 2027-04-01 | 2026-09-10 |
| (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty (Z)-endoxifen - Precocious Puberty, Gonadotropin-dependent | Phase 2 | Not yet recruiting | Atossa Therapeutics, Inc. | 6 | 2027-03-01 | 2026-10-09 |
| Recover@Home Postoperative Follow-up Study Recovery@home - Hernia, Inguinal, Hernia, Femoral | Not applicable | Not yet recruiting | Icahn School of Medicine at Mount Sinai | 194 | 2027-03-01 | 2026-07-20 |
| Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer losartan, Paclitaxel - Platinum Resistant Ovarian Cancer | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 27 | 2027-02-01 | 2026-09-22 |
| Time-Restricted Eating as a Dietary Intervention for Polyendocrine Metabolic Ovarian Syndrome (PMOS): Protocol for a Randomized Controlled Trial Time-restricted eating - Polycystic Ovary Syndrome | Not applicable | Not yet recruiting | Joanna Bajerska | 84 | 2027-01-09 | 2026-10-16 |
| Product Transference Study of Testagen™ TDS®-Testosterone Testagen® TDS Testosterone 5% HypoSpray® - Hypogonadotropism | Phase 2 | Not yet recruiting | Transdermal Delivery Solutions Corp | 96 | 2027-01-05 | 2026-05-27 |
| Helping Young People With Testicular Cancer Using Virtual and Extended Reality Digital tool using extended reality - Testicular Cancer, Testis Cancer | Not applicable | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 245 | 2027-01-04 | 2026-05-06 |
| NK521 in the Treatment of Advanced Solid Tumors NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer | Early Phase 1 | Not yet recruiting | Base Therapeutics (Shanghai) Co., Ltd. | 18 | 2027-01-01 | 2026-09-30 |
| Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia exposure to healthcare transition protocol - Congenital Adrenal Hyperplasia | Not yet recruiting | University of Alabama at Birmingham | 40 | 2027-01-01 | 2026-10-14 | |
| Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care ICG-Guided Retroperitoneal Sentinel Lymph Node Biopsy, Radical Inguinal Orchiectomy - Testicular Cancer, Testicular Germ Cell Tumor | Not applicable | Not yet recruiting | Heinrich-Heine University, Duesseldorf | 171 | 2027-01-01 | 2026-07-13 |
| Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients Tamoxifen - Hypogonadism, Prostate Cancer | Phase 2 | Recruiting | University Health Network, Toronto | 96 | 2026-12-31 | 2026-10-22 |
| Study of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab Fludarabine, Cyclophosphamide - Ovarian Cancer | Phase 2 | Not yet recruiting | Medical University of South Carolina | 20 | 2026-12-01 | 2026-07-22 |
| A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation LG00313112 - Ovarian Cancer, Small Cell Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | LG Chem | 250 | 2026-12-01 | 2026-08-07 |
| Symptoms of Polycystic Ovarian Syndrome Ameliorated by Keto-Adaptation Pilot Ketogenic diet, Exogenous Ketone Supplement - PCOS (Polycystic Ovary Syndrome) | Not applicable | Recruiting | Ohio State University | 40 | 2026-12-01 | 2026-05-08 |
| Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1 INCB123667, Bevacizumab, Placebo - Ovarian Cancer | Phase 3 | Not yet recruiting | Incyte Corporation | 590 | 2026-12-01 | 2026-10-02 |
| Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial Imlunestrant, Abemaciclib, Selinexor - Low Grade Ovarian Serous Adenocarcinoma, Endometrial Cancer | Phase 2 | Not yet recruiting | Dana-Farber Cancer Institute | 60 | 2026-12-01 | 2026-09-21 |
| Efficacy, Safety, Tolerability, and Pharmacokinetics of NBIP-01435 in Adult Participants With Classic Congenital Adrenal Hyperplasia (CAH) NBIP-01435 - Congenital Adrenal Hyperplasia | Phase 2 | Not yet recruiting | Neurocrine Biosciences | 36 | 2026-12-01 | 2026-09-30 |
Showing 20 of 5936. Sign in to see all of them.
Ovarian Neoplasms (3258) · Polycystic Ovary Syndrome (949) · Carcinoma, Ovarian Epithelial (784) · Fallopian Tube Neoplasms (782) · Breast Neoplasms (706) · Endometrial Neoplasms (457) · Neoplasms (396) · Uterine Cervical Neoplasms (369) · Carcinoma, Non-Small-Cell Lung (343) · Pancreatic Neoplasms (337) · Colorectal Neoplasms (326) · Hypogonadism (316) · Testicular Neoplasms (295) · Prostatic Neoplasms (283) · Stomach Neoplasms (274)
Endocrine System Diseases (5896) · Urogenital Diseases (5576) · Female Urogenital Diseases and Pregnancy Complications (5344) · Female Urogenital Diseases (5343) · Genital Diseases (5245) · Genital Diseases, Female (4953) · Adnexal Diseases (4944) · Ovarian Diseases (4910) · Neoplasms (4527) · Neoplasms by Site (3886) · Urogenital Neoplasms (3861) · Endocrine Gland Neoplasms (3844) · Genital Neoplasms, Female (3664) · Neoplasms by Histologic Type (1558)
Paclitaxel (389) · Carboplatin (388) · Bevacizumab (207) · Metformin (174) · Cisplatin (127) · Gemcitabine (125) · liposomal doxorubicin (122) · pembrolizumab (119) · Cyclophosphamide (110) · Testosterone (107) · Topotecan (104) · olaparib (100) · niraparib (74) · Taxes (72) · Clomiphene (70)
National Cancer Institute (NCI) (202) · Memorial Sloan Kettering Cancer Center (88) · M.D. Anderson Cancer Center (86) · Gynecologic Oncology Group (77) · AstraZeneca (66) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (46) · Eli Lilly and Company (40) · Cairo University (38) · Dana-Farber Cancer Institute (37) · Mayo Clinic (37) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (36) · Massachusetts General Hospital (36) · Assiut University (33) · University of Virginia (33) · University Health Network, Toronto (31)
United States (2675) · China (594) · France (433) · Italy (404) · United Kingdom (389) · Canada (365) · Spain (339) · Germany (264) · Belgium (230) · South Korea (214) · Australia (212) · Netherlands (189) · Denmark (184) · Turkey (Türkiye) (164) · Egypt (159)
Lei Li, M.D. (14) · Stefano Palomba, MD (14) · Paul Sabbatini, MD (13)
PMID 37185961, PMID 37407274, PMID 35170751, PMID 27008889, PMID 37462232, PMID 39695768, PMID 19238149, PMID 30633128, PMID 38224135, PMID 20818904, PMID 23922302, PMID 26961146, PMID 29342393, PMID 29486615, PMID 35537408, PMID 36512649, PMID 36978128, PMID 39019698, PMID 41868592, PMID 42014131, PMID 42693220, PMID 14688154, PMID 16394300, PMID 18158291, PMID 20424285, PMID 21324454, PMID 21941283, PMID 26707054, PMID 28981994, PMID 30796792, PMID 31132118, PMID 31547562, PMID 32034419, PMID 32195207, PMID 33347618, PMID 33527139, PMID 33538338, PMID 34904813, PMID 35262624, PMID 35397664, PMID 40132910, PMID 40785326, PMID 41044356, PMID 12826431, PMID 16882940, PMID 16966687, PMID 17000396, PMID 17949799, PMID 18480812, PMID 19282241
U10CA027469 (59), U10CA180868 (45), 2023 (39), 2018 (27), 2025 (22), 2009 (21), 2017 (20), 2008 (19), 2015 (19), P30CA033572 (19), 2016 (18), P30CA015083 (14), 2019 (13), U10CA101165 (11), P30CA043703 (10)